THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

GSA CAPITAL PARTNERS LLP's Holding History (CIK: 0001362033)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 58,379 Value ($000) $1 Avg Close $16.59 Range $13.50 - $20.33
Q3 2025
Shares 92,181 Value ($000) $1 Avg Close $12.64 Range $10.82 - $14.87
Q2 2025
Shares 137,951 Value ($000) $2 Avg Close $9.72 Range $7.90 - $11.82
Q1 2025
Shares 182,350 Value ($000) $2 Avg Close $9.31 Range $8.35 - $10.90
Q4 2024
Shares 162,987 Value ($000) $2 Avg Close $9.10 Range $7.88 - $10.26
Q3 2024
Shares 229,780 Value ($000) $2 Avg Close $8.66 Range $7.44 - $10.42
Q2 2024
Shares 204,089 Value ($000) $2 Avg Close $9.03 Range $8.13 - $10.44
Q4 2023
Shares 77,070 Value ($000) $1 Avg Close $10.06 Range $8.52 - $11.57
Q3 2023
Shares 325,985 Value ($000) $3 Avg Close $9.65 Range $8.25 - $10.59
Q2 2023
Shares 19,921 Value ($000) $0 Avg Close $11.04 Range $9.98 - $12.03
Q1 2023
Shares 105,263 Value ($000) $1 Avg Close $10.57 Range $9.25 - $11.52
Q4 2022
Shares 57,577 Value ($000) $1 Avg Close $10.51 Range $9.56 - $11.83
Q2 2022
Shares 114,646 Value ($000) $1,039 Avg Close $9.21 Range $8.15 - $10.52
Q1 2022
Shares 49,456 Value ($000) $473 Avg Close $9.80 Range $7.71 - $13.17
Q3 2020
Shares 13,965 Value ($000) $206 Avg Close $18.73 Range $14.62 - $22.82
Q3 2019
Shares 10,745 Value ($000) $209 Avg Close $20.20 Range $16.00 - $24.34